Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients, \>/= 18 years of age
Moderate to severe rheumatoid arthritis according to revised (1987) American college of rheumatology (ACR) criteria
Initiated on tocilizumab treatment by the treating physician in accordance with the Canadian product monograph
Informed consent to data being subject to computerized data processing
Participant must fulfill the reimbursement criteria for treatment with tocilizumab under provincial or private health insurance coverage
You may not be if
Received tocilizumab prior to enrolment visit
Previously received tocilizumab in a clinical trial or for compassionate use
Enrolled in an ongoing clinical trial and/or received treatment with any investigational agent within 4 weeks, or 5 half-lives of the investigational agent, whichever is longer, before starting treatment with tocilizumab
Participation in another clinical trial or industry sponsored observational study
History of autoimmune disease or any joint inflammatory disease other than rheumatoid arthritis, with the exception of concomitant secondary Sjörgen's syndrome
